Inherited and acquired alterations in development of breast cancer

References

• WillemsPGSusceptibility genes in breast cancer: more is less?Clin Genet200772493496
   Web of Science ®Google Scholar
• AndersonWFJatoiITseJRosenbergPSMale breast cancer: a population-based comparison with female breast cancerJ Clin Oncol20102823223919996029
   PubMed Web of Science ®Google Scholar
• MartinAMWeberBLGenetic and hormonal risk factors in breast cancerJ Natl Cancer Inst2000921126113510904085
   PubMed Web of Science ®Google Scholar
• ThompsonDEastonDThe genetic epidemiology of breast cancer genesJ Mammary Gland Biol Neoplasia2004922123615557796
   PubMed Web of Science ®Google Scholar
• LeeEYMullerWJOncogenes and tumor suppressor genesCold Spring Harb Perspect Biol20102a00323620719876
   PubMed Web of Science ®Google Scholar
• StephensPJMcBrideDJLinMLComplex landscapes of somatic rearrangement in human breast cancer genomesNature20094621005101020033038
   PubMed Web of Science ®Google Scholar
• EstellerMCancer epigenomics: DNA methylomes and histone-modification mapsNat Rev Genet2007828629817339880
   PubMed Web of Science ®Google Scholar
• CroceCMCauses and consequences of microRNA dysregulation in cancerNat Rev Genet20091070471419763153
   PubMed Web of Science ®Google Scholar
• HirshfieldKMRebbeckTRLevineAJGermline mutations and polymorphisms in the origins of cancers in womenJ Oncol2010 Epub 2010 Jan 10
   Google Scholar
• BorresenALAndersenTIGarberJScreening for germ line TP53 mutations in breast cancer patientsCancer Res199252323432361591732
   PubMed Web of Science ®Google Scholar
• ChenJLindblomPLindblomAA study of the PTEN/MMAC1 gene in 136 breast cancer familiesHum Genet19981021241259490290
   PubMed Web of Science ®Google Scholar
• WoosterRWeberBLBreast and ovarian cancerN Engl J Med20033482339234712788999
   PubMed Web of Science ®Google Scholar
• StrattonMRRahmanNThe emerging landscape of breast cancer susceptibilityNat Genet200840172218163131
   PubMed Web of Science ®Google Scholar
• NathansonKLWoosterRWeberBLBreast cancer genetics: what we know and what we needNat Med2001755255611329055
   PubMed Web of Science ®Google Scholar
• MartinAMBlackwoodMAAntin-OzerkisDGermline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinicJ Clin Oncol2001192247225311304778
   PubMed Web of Science ®Google Scholar
• LiebensFPCarlyBPastijnARozenbergSManagement of BRCA1/2 associated breast cancer: a systematic qualitative review of the state of knowledge in 2006Eur J Cancer20074323825717095205
   PubMed Web of Science ®Google Scholar
• FordDEastonDFStrattonMGenetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage ConsortiumAm J Hum Genet1998626766899497246
   PubMed Web of Science ®Google Scholar
• AntoniouAPharoahPDNarodSAverage risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studiesAm J Hum Genet2003721117113012677558
   PubMed Web of Science ®Google Scholar
• ChenSIversenESFriebelTCharacterization of BRCA1 and BRCA2 mutations in a large United States sampleJ Clin Oncol20062486387116484695
   PubMed Web of Science ®Google Scholar
• FrankTSDeffenbaughAMReidJEClinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individualsJ Clin Oncol2002201480149011896095
   PubMed Web of Science ®Google Scholar
• OttiniLRizzoloPZannaIBRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central ItalyBreast Cancer Res Treat200911657758618819001
   PubMed Web of Science ®Google Scholar
• PapiLPutignanoALCongregatiCFounder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central ItalyBreast Cancer Res Treat200911749750418821011
   PubMed Web of Science ®Google Scholar
• DurocherFShattuck-EidensDMcClureMComparison of BRCA1 polymorphisms, rare sequence variants and/or missense mutations in unaffected and breast/ovarian cancer populationsHum Mol Genet199658358428776600
   PubMed Web of Science ®Google Scholar
• DunningAMChianoMSmithNRCommon BRCA1 variants and susceptibility to breast and ovarian cancer in the general populationHum Mol Genet199762852899063749
   PubMed Web of Science ®Google Scholar
• QiuLXYaoLXueKBRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjectsBreast Cancer Res Treat201012348749020135345
   PubMed Web of Science ®Google Scholar
• PalliDFalchettiMMasalaGAssociation between the BRCA2 N372H variant and male breast cancer risk: a population-based case-control study in Tuscany, Central ItalyBMC Cancer2007717017767707
   PubMed Web of Science ®Google Scholar
• ThompsonDEastonDBreast Cancer Linkage Consortium. Variation in cancer risks, by mutation position, in BRCA2 mutation carriersAm J Hum Genet20016841041911170890
   PubMed Web of Science ®Google Scholar
• ThompsonDEastonDBreast Cancer Linkage Consortium. Variation in BRCA1 cancer risks by mutation positionCancer Epidemiol Biomarkers Prev20021132933611927492
   PubMed Web of Science ®Google Scholar
• PhelanCMKwanEJackEA low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer familiesHum Mutat20022035235712402332
   PubMed Web of Science ®Google Scholar
• StruewingJPAbeliovichDPeretzTThe carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individualsNat Genet1995111982007550349
   PubMed Web of Science ®Google Scholar
• GudmundssonJJohannesdottirGArasonAFrequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotypeAm J Hum Genet1996587497568644738
   PubMed Web of Science ®Google Scholar
• ThorlaciusSOlafsdottirGTryggvadottirLA single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypesNat Genet1996131171198673089
   PubMed Web of Science ®Google Scholar
• JohannesdottirGGudmundssonJBergthorssonJTHigh prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patientsCancer Res199656366336658706004
   PubMed Web of Science ®Google Scholar
• BaudiFQuaresimaBGrandinettiCEvidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancerHum Mutat20011816316411462242
   PubMedGoogle Scholar
• RussoACalòVBrunoLIs BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? Breast Cancer Res Treat2009113677018228134
   PubMed Web of Science ®Google Scholar
• CaligoMAGhimentiCCipolliniGBRCA1 germline mutational spectrum in Italian families from Tuscany: a high frequency of novel mutationsOncogene199613148314888875986
   PubMed Web of Science ®Google Scholar
• SluiterMDvan RensburgEJLarge genomic rearrangements of the BRCA1 and BRCA2 genes: review of the literature and report of a novel BRCA1 mutationBreast Cancer Res Treat201112532534920232141
   PubMed Web of Science ®Google Scholar
• HansenTOJønsonLAlbrechtsenAAndersenMKEjlertsenBNielsenFCLarge BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer familiesBreast Cancer Res Treat200911531532318546071
   PubMed Web of Science ®Google Scholar
• KarhuRLaurilaEKallioniemiASyrjäkoskiKLarge genomic BRCA2 rearrangements and male breast cancerCancer Detect Prev20063053053417113724
   PubMedGoogle Scholar
• WoodwardAMDavisTASilvaAGKirkJALearyJAkConFab InvestigatorsLarge genomic rearrangements of both BRCA2 and BRCA1 are a feature of the inherited breast/ovarian cancer phenotype in selected familiesJ Med Genet200542e3115863663
   PubMed Web of Science ®Google Scholar
• WalshTCasadeiSCoatsKHSpectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancerJAMA20062951379138816551709
   PubMed Web of Science ®Google Scholar
• WangTLererIGuetaZA deletion/insertion mutation in the BRCA2 gene in a breast cancer family: a possible role of the Alu-polyA tail in the evolution of the deletionGenes Chromosomes Cancer200131919511284040
   PubMed Web of Science ®Google Scholar
• TournierIPailleretsBBSobolHSignificant contribution of germline BRCA2 rearrangements in male breast cancer familiesCancer Res2004648143814715548676
   PubMed Web of Science ®Google Scholar
• Gutiérrez-EnríquezSde la HoyaMMartínez-BouzasCScreening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancerBreast Cancer Res Treat200710310310717063271
   PubMed Web of Science ®Google Scholar
• Meijers-HeijboerHvan den OuwelandAKlijnJLow-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsNat Genet20023555911967536
   PubMed Web of Science ®Google Scholar
• WeischerMBojesenSEEllervikCTybjaerg-HansenANordestgaardBGCHEK2*1100delC genotyping for clinical assessment of breast cancer risk: meta-analyses of 26,000 patient cases and 27,000 controlsJ Clin Oncol20082654254818172190
   PubMed Web of Science ®Google Scholar
• NeuhausenSDunningASteeleLRole of CHEK2*1100delC in unselected series of non-BRCA1/2 male breast cancersInt J Cancer200410847747814648718
   PubMed Web of Science ®Google Scholar
• OhayonTGalIBaruchRGSzaboCFriedmanECHEK2*1100delC and male breast cancer risk in IsraelInt J Cancer200410847948014648719
   PubMed Web of Science ®Google Scholar
• SyrjäkoskiKKuukasjärviTAuvinenAKallioniemiOPCHEK2 1100delC is not a risk factor for male breast cancer populationInt J Cancer200410847547614648717
   PubMed Web of Science ®Google Scholar
• FalchettiMLupiRRizzoloPBRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer casesBreast Cancer Res Treat200811016116717661168
   PubMed Web of Science ®Google Scholar
• Martinez-BouzasCBeristainEGuerraICHEK2 1100delC is present in familial breast cancer cases of the Basque CountryBreast Cancer Res Treat200710311111317063278
   PubMed Web of Science ®Google Scholar
• NarodSALynchHTCHEK2 mutation and hereditary breast cancerJ Clin Oncol2007256717132696
   PubMed Web of Science ®Google Scholar
• CaligoMAAgataSAcetoGThe CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in ItalyHum Mutat20042410010115221794
   PubMed Web of Science ®Google Scholar
• SchutteMSealSBarfootRBreast Cancer Linkage Consortium. Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilityAm J Hum Genet2003721023102812610780
   PubMed Web of Science ®Google Scholar
• BogdanovaNEnssen-DubrowinskajaNFeshchenkoSAssociation of two mutations in the CHEK2 gene with breast cancerInt J Cancer200511626326615810020
   PubMed Web of Science ®Google Scholar
• SwiftMReitnauerPJMorrellDChaseCLBreast and other cancers in families with ataxia-telangiectasiaN Engl J Med1987316128912943574400
   PubMed Web of Science ®Google Scholar
• ThompsonDDuedalSKirnerJCancer risks and mortality in heterozygous ATM mutation carriersJ Natl Cancer Inst20059781382215928302
   PubMedGoogle Scholar
• RenwickAThompsonDSealSATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility allelesNat Genet20063887387516832357
   PubMed Web of Science ®Google Scholar
• Levy-LahadEFanconi anemia and breast cancer susceptibility meet againNat Genet20104236836920428093
   PubMed Web of Science ®Google Scholar
• RahmanNSealSThompsonDPALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility geneNat Genet20073916516717200668
   PubMed Web of Science ®Google Scholar
• TischkowitzMXiaBSabbaghianNAnalysis of PALB2/FANCN-associated breast cancer familiesProc Natl Acad Sci USA20071046788679317420451
   PubMed Web of Science ®Google Scholar
• CaoAYHuangJHuZThe prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relativesBreast Cancer Res Treat200911445746218446436
   PubMed Web of Science ®Google Scholar
• HeikkinenTKärkkäinenHAaltonenKThe breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotypeClin Cancer Res2009153214322219383810
   PubMed Web of Science ®Google Scholar
• PapiLPutignanoALCongregatiCA PALB2 germline mutation associated with hereditary breast cancer in ItalyFam Cancer2010918118519763884
   PubMed Web of Science ®Google Scholar
• Dansonka-MieszkowskaAKluskaAMoesJA novel germline PALB2 deletion in Polish breast and ovarian cancer patientsBMC Med Genet2010112020122277
   PubMed Web of Science ®Google Scholar
• SluiterMMewSvan RensburgEJPALB2 sequence variants in young South African breast cancer patientsFam Cancer2009834735319333784
   PubMed Web of Science ®Google Scholar
• GarcíaMJFernándezVOsorioAAnalysis of FANCB and FANCN/PALB2 Fanconi anemia genes in BRCA1/2-negative Spanish breast cancer familiesBreast Cancer Res Treat200911354555118302019
   PubMed Web of Science ®Google Scholar
• BaliaCSensiELombardiGRoncellaMBevilacquaGCaligoMAPALB2: a novel inactivating mutation in a Italian breast cancer familyFam Cancer2010953153620852946
   PubMed Web of Science ®Google Scholar
• DingYCSteeleLChuLHGermline mutations in PALB2 in African-American breast cancer casesBreast Cancer Res Treat201112622723021113654
   PubMed Web of Science ®Google Scholar
• ErkkoHXiaBNikkiläJA recurrent mutation in PALB2 in Finnish cancer familiesNature200744631631917287723
   PubMed Web of Science ®Google Scholar
• FoulkesWDGhadirianPAkbariMRIdentification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian womenBreast Cancer Res20079R8318053174
   PubMed Web of Science ®Google Scholar
• Sauty de ChalonATeoZParkDJAre PALB2 mutations associated with increased risk of male breast cancer?Breast Cancer Res Treat201012125325520091115
   PubMed Web of Science ®Google Scholar
• SilvestriVRizzoloPZannaIPALB2 mutations in male breast cancer: a population-based study in Central ItalyBreast Cancer Res Treat201012229930120180015
   PubMed Web of Science ®Google Scholar
• AdankMAvan MilSEGilleJJWaisfiszQMeijers-HeijboerHPALB2 analysis in BRCA2-like familiesBreast Cancer Res Treat201112735736220582465
   PubMed Web of Science ®Google Scholar
• DingYCSteeleLKuanCJGreilacSNeuhausenSLMutations in BRCA2 and PALB2 in male breast cancer cases from the United StatesBreast Cancer Res Treat201112677177820927582
   PubMed Web of Science ®Google Scholar
• CasadeiSNorquistBMWalshTContribution to familial breast cancer of inherited mutations in the BRCA2-interacting protein PALB2Cancer Res2011712222222921285249
   PubMed Web of Science ®Google Scholar
• SealSThompsonDRenwickATruncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility allelesNat Genet2006381239124117033622
   PubMed Web of Science ®Google Scholar
• KarppinenSMVuoskuJHeikkinenKAllinenMWinqvistRNo evidence of involvement of germline BACH1 mutations in Finnish breast and ovarian cancer familiesEur J Cancer20033936637112565990
   PubMed Web of Science ®Google Scholar
• GuénardFLabrieYOuelletteGMutational analysis of the breast cancer susceptibility gene BRIP1/BACH1/FANCJ in high-risk non-BRCA1/BRCA2 breast cancer familiesJ Hum Genet20085357959118414782
   PubMed Web of Science ®Google Scholar
• CaoAYHuangJHuZMutation analysis of BRIP1/BACH1 in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relativesBreast Cancer Res Treat2009115515518483852
   PubMed Web of Science ®Google Scholar
• LewisAGFlanaganJMarshAMutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancerBreast Cancer Res20057R1005R101616280053
   PubMed Web of Science ®Google Scholar
• De NicoloATancrediMLombardiGA novel breast cancer-associated BRIP1 (FANCJ/BACH1) germ-line mutation impairs protein stability and functionClin Cancer Res2008144672468018628483
   PubMed Web of Science ®Google Scholar
• SilvestriVRizzoloPFalchettiMMutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central ItalyBreast Cancer Res Treat201112653954321165771
   PubMed Web of Science ®Google Scholar
• MeindlAHellebrandHWiekCGermline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility geneNat Genet20104241041420400964
   PubMed Web of Science ®Google Scholar
• AkbariMRToninPFoulkesWDGhadirianPTischkowitzMNarodSARAD51C germline mutations in breast and ovarian cancer patientsBreast Cancer Res20101240420723205
   PubMed Web of Science ®Google Scholar
• ZhengYZhangJHopeKNiuQHuoDOlopadeOIScreening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancerBreast Cancer Res Treat201012485786120697805
   PubMed Web of Science ®Google Scholar
• SilvestriVRizzoloPFalchettiMMutation screening of RAD51C in male breast cancer patientsBreast Cancer Res20111340421392410
   PubMed Web of Science ®Google Scholar
• PharoahPDAntoniouABobrowMZimmernRLEastonDFPonderBAPolygenic susceptibility to breast cancer and implications for preventionNat Genet200231333611984562
   PubMed Web of Science ®Google Scholar
• Breast Cancer Association ConsortiumCommonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association ConsortiumJ Natl Cancer Inst2006981382139617018785
   PubMedGoogle Scholar
• EastonDFPooleyKADunningAMGenome-wide association study identifies novel breast cancer susceptibility lociNature20074471087109317529967
   PubMed Web of Science ®Google Scholar
• CoxADunningAMGarcia-ClosasMA common coding variant in CASP8 is associated with breast cancer riskNat Genet20073935235817293864
   PubMed Web of Science ®Google Scholar
• StaceySNManolescuASulemPCommon variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancerNat Genet20084070370618438407
   PubMed Web of Science ®Google Scholar
• ThomasGJacobsKBKraftPA multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)Nat Genet20094157958419330030
   PubMed Web of Science ®Google Scholar
• DunningAMHealeyCSBaynesCAssociation of ESR1 gene tagging SNPs with breast cancer riskHum Mol Genet2009181131113919126777
   PubMed Web of Science ®Google Scholar
• TurnbullCAhmedSMorrisonJGenome-wide association study identifies five new breast cancer susceptibility lociNat Genet20104250450720453838
   PubMed Web of Science ®Google Scholar
• FletcherOHoulstonRSArchitecture of inherited susceptibility to common cancerNat Rev Cancer20101035336120414203
   PubMed Web of Science ®Google Scholar
• AntoniouACSpurdleABSinilnikovaOMCommon breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriersAm J Hum Genet20088293794818355772
   PubMed Web of Science ®Google Scholar
• WassermanNFAneasINobregaMAAn 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancerGenome Res2010201191119720627891
   PubMed Web of Science ®Google Scholar
• GhoussainiMSongHKoesslerTMultiple loci with different cancer specificities within the 8q24 gene desertJ Natl Cancer Inst200810096296618577746
   PubMedGoogle Scholar
• WokołorczykDLubińskiJNarodSACybulskiCGenetic heterogeneity of 8q24 region in susceptibility to cancerJ Natl Cancer Inst200910127827919211453
   PubMedGoogle Scholar
• WokolorczykDGliniewiczBSikorskiAA range of cancers is associated with the rs6983267 marker on chromosome 8Cancer Res2008689982998619047180
   PubMed Web of Science ®Google Scholar
• BonifaciNGórskiBMasojćBExploring the link between germline and somatic genetic alterations in breast carcinogenesisPLoS One20105e1407821124932
   PubMed Web of Science ®Google Scholar
• StaceySNManolescuASulemPCommon variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancerNat Genet20073986586917529974
   PubMed Web of Science ®Google Scholar
• Garcia-ClosasMChanockSGenetic susceptibility loci for breast cancer by estrogen receptor statusClin Cancer Res2008148000800919088016
   PubMed Web of Science ®Google Scholar
• WoodLDParsonsDWJonesSThe genomic landscapes of human breast and colorectal cancersScience20073181108111317932254
   PubMed Web of Science ®Google Scholar
• GreenmanCStephensPSmithRPatterns of somatic mutation in human cancer genomesNature200744615315817344846
   PubMed Web of Science ®Google Scholar
• BachmanKEArganiPSamuelsYThe PIK3CA gene is mutated with high frequency in human breast cancersCancer Biol Ther2004377277515254419
   PubMed Web of Science ®Google Scholar
• SaalLHHolmKMaurerMPIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinomaCancer Res2005652554255915805248
   PubMed Web of Science ®Google Scholar
• LiSYRongMGrieuFIacopettaBPIK3CA mutations in breast cancer are associated with poor outcomeBreast Cancer Res Treat200696919516317585
   PubMed Web of Science ®Google Scholar
• MaruyamaNMiyoshiYTaguchiTTamakiYMondenMNoguchiSClinicopathologic analysis of breast cancers with PIK3CA mutations in Japanese womenClin Cancer Res2007132 Pt 140841417202311
   PubMed Web of Science ®Google Scholar
• JongYJLiLHTsouMHChromosomal comparative genomic hybridization abnormalities in early- and late-onset human breast cancers: correlation with disease progression and TP53 mutationsCancer Genet Cytogenet2004148556514697642
   PubMedGoogle Scholar
• LangerødAZhaoHBorganØTP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancerBreast Cancer Res20079R3017504517
   PubMed Web of Science ®Google Scholar
• HolstegeHJoosseSAvan OostromCTNederlofPMde VriesAJonkersJHigh incidence of protein-truncating TP53 mutations in BRCA1-related breast cancerCancer Res2009693625363319336573
   PubMed Web of Science ®Google Scholar
• Al-KurayaKSchramlPTorhorstJPrognostic relevance of gene amplifications and coamplifications in breast cancerCancer Res2004648534854015574759
   PubMed Web of Science ®Google Scholar
• SunamiEShinozakiMSimMSEstrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumorsBreast Cancer Res200810R4618485221
   PubMed Web of Science ®Google Scholar
• Nana-SinkamSPCroceCMMicroRNAs as therapeutic targets in cancerTransl Res201115721622521420032
   PubMed Web of Science ®Google Scholar
• LereboursFLidereauRMolecular alterations in sporadic breast cancerCrit Rev Oncol Hematol20024412114112413631
   PubMed Web of Science ®Google Scholar
• BellDWOur changing view of the genomic landscape of cancerJ Pathol201022023124319918804
   PubMed Web of Science ®Google Scholar
• KanZJaiswalBSStinsonJDiverse somatic mutation patterns and pathway alterations in human cancersNature201046686987320668451
   PubMed Web of Science ®Google Scholar
• ArnoldJMChoongDYThompsonERFrequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumorsBreast Cancer Res Treat201011949149619189213
   PubMed Web of Science ®Google Scholar
• CampbellIGRussellSEChoongDYMutation of the PIK3CA gene in ovarian and breast cancerCancer Res2004647678768115520168
   PubMed Web of Science ®Google Scholar
• ButtittaFFelicioniLBarassiFPIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinomaJ Pathol200620835035516353168
   PubMed Web of Science ®Google Scholar
• DunlapJLeCShuklaAPhosphatidylinositol-3-kinase and AKT1 mutations occur early in breast carcinomaBreast Cancer Res Treat201012040941819418217
   PubMed Web of Science ®Google Scholar
• BenvenutiSFrattiniMArenaSPIK3CA cancer mutations display gender and tissue specificity patternsHum Mutat20082928428818022911
   PubMed Web of Science ®Google Scholar
• BaderAGKangSZhaoLVogtPKOncogenic PI3K deregulates transcription and translationNat Rev Cancer2005592192916341083
   PubMed Web of Science ®Google Scholar
• Børresen-DaleALTP53 and breast cancerHum Mutat20032129230012619115
   PubMed Web of Science ®Google Scholar
• OlivierMHainautPTP53 mutation patterns in breast cancers: searching for clues of environmental carcinogenesisSemin Cancer Biol20011135336011562177
   PubMed Web of Science ®Google Scholar
• McKinziePBDelongchampRRHeflichRHParsonsBLProspects for applying genotypic selection of somatic oncomutation to chemical risk assessmentMutat Res2001489477811673089
   PubMed Web of Science ®Google Scholar
• PietschECHumbeyOMurphyMEPolymorphisms in the p53 pathwayOncogene2006251602161116550160
   PubMed Web of Science ®Google Scholar
• DaminAPFrazzonAPDaminDCEvidence for an association of TP53 codon 72 polymorphism with breast cancer riskCancer Detect Prev20063052352917113725
   PubMedGoogle Scholar
• KhadangBFattahiMJTaleiADehaghaniASGhaderiAPolymorphism of TP53 codon 72 showed no association with breast cancer in Iranian womenCancer Genet Cytogenet2007173384217284368
   PubMedGoogle Scholar
• OsorioAMartínez-DelgadoBPollánMA haplotype containing the p53 polymorphisms Ins16bp and Arg72Pro modifies cancer risk in BRCA2 mutation carriersHum Mutat20062724224816419081
   PubMed Web of Science ®Google Scholar
• MartinAMKanetskyPAAmirimaniBGermline TP53 mutations in breast cancer families with multiple primary cancers: is TP53 a modifier of BRCA1? J Med Genet200340e3412676907
   PubMed Web of Science ®Google Scholar
• VenablesJPKlinckRBramardAIdentification of alternative splicing markers for breast cancerCancer Res2008689525953119010929
   PubMed Web of Science ®Google Scholar
• WatsonPMWatsonDKAlternative splicing in prostate and breast cancerThe Open Cancer Journal201036276
   Google Scholar
• OrbanTIOlahEEmerging roles of BRCA1 alternative splicingMol Pathol20035619119712890739
   PubMedGoogle Scholar
• CastiglioniFTagliabueECampiglioMPupaSMBalsariAMénardSRole of exon-16-deleted HER2 in breast carcinomasEndocr Relat Cancer20061322123216601290
   PubMed Web of Science ®Google Scholar
• AndréFMichielsSDessenPExonic expression profiling of breast cancer and benign lesions: a retrospective analysisLancet Oncol20091038139019249242
   PubMed Web of Science ®Google Scholar
• LaVoieHADeSimoneDCGillio-MeinaCHuiYYCloning and characterization of porcine ovarian estrogen receptor β isoformsBiol Reprod20026661662311870066
   PubMed Web of Science ®Google Scholar
• KwongKYHungMA novel splice variant of HER2 with increased transformation activityMol Carcinog19982362689808159
   PubMed Web of Science ®Google Scholar
• RodriguezCHughes-DaviesLVallèsHAmplification of the BRCA2 pathway gene EMSY in sporadic breast cancer is related to negative outcomeClin Cancer Res2004105785579115355907
   PubMed Web of Science ®Google Scholar
• CiampaAXuBAyataGHER-2 status in breast cancer: correlation of gene amplification by FISH with immunohistochemistry expression using advanced cellular imaging systemAppl Immunohistochem Mol Morphol20061413213716785779
   PubMedGoogle Scholar
• Vanden BemptIDrijkoningenMDe Wolf-PeetersCThe complexity of genotypic alterations underlying HER2-positive breast cancer: an explanation for its clinical heterogeneityCurr Opin Oncol20071955255717906451
   PubMed Web of Science ®Google Scholar
• RossJSFletcherJAThe HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapyStem Cells1998164134289831867
   PubMed Web of Science ®Google Scholar
• FrancisGBeadleGThomasSMengersenKSteinSEvaluation of oestrogen and progesterone receptor status in HER-2 positive breast carcinomas and correlation with outcomePathology20063839139817008275
   PubMed Web of Science ®Google Scholar
• StratfordALFryCJDesiletsCY-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cellsBreast Cancer Res200810R9919036157
   PubMed Web of Science ®Google Scholar
• TsutsuiSOhnoSMurakamiSHachitandaYOdaSPrognostic value of epidermal growth factor receptor (EGFR) and its relationship to the estrogen receptor status in 1029 patients with breast cancerBreast Cancer Res Treat200271677511859875
   PubMed Web of Science ®Google Scholar
• UberallIKolárZTrojanecRBerkovcováJHajdúchMThe status and role of ErbB receptors in human cancerExp Mol Pathol200884798918279851
   PubMed Web of Science ®Google Scholar
• ToyamaTYamashitaHKondoNFrequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancersBMC Cancer2008830918950515
   PubMed Web of Science ®Google Scholar
• ChenYMYC in breast tumor progressionExpert Rev Anticancer Ther200881689169818925859
   PubMed Web of Science ®Google Scholar
• HolstFStahlPRRuizCEstrogen receptor alpha (ESR1) gene amplification is frequent in breast cancerNat Genet20073965566017417639
   PubMed Web of Science ®Google Scholar
• RoyPGThompsonAMCyclin D1 and breast cancerBreast20061571872716675218
   PubMed Web of Science ®Google Scholar
• CourjalFLouasonGSpeiserPKatsarosDZeillingerRTheilletCCyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumorsInt J Cancer1996692472538797862
   PubMed Web of Science ®Google Scholar
• BärlundMMonniOKononenJMultiple genes at 17q23 undergo amplification and overexpression in breast cancerCancer Res2000605340534411034067
   PubMed Web of Science ®Google Scholar
• KirkegaardTNielsenKVJensenLBGenetic alterations of CCND1 and EMSY in breast cancersHistopathology20085269870518393977
   PubMed Web of Science ®Google Scholar
• TanDSMarchiòCReis-FilhoJSHereditary breast cancer: from molecular pathology to tailored therapiesJ Clin Pathol2008611073108218682420
   PubMed Web of Science ®Google Scholar
• TommasiSMangiaAIannelliGGene copy number variation in male breast cancer by aCGHAnal Cell Pathol (Amst)20103311311921045282
   PubMedGoogle Scholar
• FonsecaRRTomásARAndréSSoaresJEvaluation of ERBB2 gene status and chromosome 17 anomalies in male breast cancerAm J Surg Pathol2006301292129817001161
   PubMed Web of Science ®Google Scholar
• BärlundMKuukasjärviTSyrjäkoskiKAuvinenAKallioniemiAFrequent amplification and overexpression of CCND1 in male breast cancerInt J Cancer200411196897115300811
   PubMed Web of Science ®Google Scholar
• DworkinAMHuangTHMEwart TolandAEpigenetic alterations in the breast: implications for breast cancer detection, prognosis and treatmentSemin Cancer Biol20091916517119429480
   PubMed Web of Science ®Google Scholar
• JovanovicaJAnders RønnebergbJTostJKristensenaVThe epigenetics of breast cancerMol Oncol2010424225420627830
   PubMed Web of Science ®Google Scholar
• LapidusRFergusonATOttavianoYLMethylation of estrogen and progesterone receptor gene 50 CpG islands correlates with lack of estrogen and progesterone receptor gene expression in breast tumorsClin Cancer Res199628058109816234
   PubMed Web of Science ®Google Scholar
• BaeYKBrownAGarrettEHypermethylation in histologically distinct classes of breast cancerClin Cancer Res2004105998600515447983
   PubMed Web of Science ®Google Scholar
• FacklerMJMcVeighMEvronEDNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinomaCancer2003107970975
   Web of Science ®Google Scholar
• LiSRongMIacopettaBDNA hypermethylation in breast cancer and its association with clinicopathological featuresCancer Lett200623727228016029926
   PubMed Web of Science ®Google Scholar
• FengWShenLWenSCorrelation between CpG methylation profiles and hormone receptor status in breast cancersBreast Cancer Res20079R5717764565
   PubMed Web of Science ®Google Scholar
• ParrellaPPoetaMLGalloAPNonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumorsClin Cancer Res2004105349535415328171
   PubMed Web of Science ®Google Scholar
• WidschwendterMSiegmundKDMullerHMAssociation of breast cancer DNA methylation profiles with hormone receptor status and response to tamoxifenCancer Res2004643807381315172987
   PubMed Web of Science ®Google Scholar
• ShenoudaSKAlahariSKMicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev20092836937820012925
   PubMed Web of Science ®Google Scholar
• IorioMVFerracinMLiuCGMicroRNA gene expression deregulation in human breast cancerCancer Res2005657065707016103053
   PubMed Web of Science ®Google Scholar
• ShiMGuoNMicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancerCancer Treat Rev20093532833419171434
   PubMed Web of Science ®Google Scholar
• PngKJYoshidaMZhangXHMicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerGenes Dev20112522623121289068
   PubMed Web of Science ®Google Scholar
• FassanMBaffaRPalazzoJPMicroRNA expression profiling of male breast cancerBreast Cancer Res200911R5819664288
   PubMed Web of Science ®Google Scholar
• LehmannUStreichertTOttoBIdentification of differentially expressed microRNAs in human male breast cancerBMC Cancer20101010920331864
   PubMed Web of Science ®Google Scholar
• SempereLFChristensenMSilahtarogluAAltered microRNA expression confined to specific epithelial cell subpopulations in breast cancerCancer Res200767116121162018089790
   PubMed Web of Science ®Google Scholar
• YanLXHuangXFShaoQMicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosisRNA2008142348236018812439
   PubMed Web of Science ®Google Scholar
• OttiniLCapalboCRizzoloPHER2-positive male breast cancer: an updateBreast Cancer: Targets and Therapy201024558
   Google Scholar
• SaxenaRDwivediAErbB family receptor inhibitors as therapeutic agents in breast cancer: current status and future clinical perspectiveMed Res RevOctober 252010 [Epub ahead of print]
   PubMed Web of Science ®Google Scholar